Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Jul;59(3):243-51.
doi: 10.1007/s00228-003-0608-0. Epub 2003 May 22.

Paracetamol and metabolite pharmacokinetics in infants

Affiliations
Clinical Trial

Paracetamol and metabolite pharmacokinetics in infants

Caroline D van der Marel et al. Eur J Clin Pharmacol. 2003 Jul.

Abstract

Background: Data concerning metabolism of paracetamol in infants are scant. Previous studies have examined urinary metabolite recovery rates after a single dose of paracetamol in either neonates (<6 weeks) or children (3-9 years). There are no studies investigating infants.

Methods: Infants ( n=47) undergoing major craniofacial surgery were given paracetamol 19-45 mg/kg 6-, 8-, or 12-hourly as either elixir or suppository formulation for postoperative analgesia, after a loading dose of 33-59 mg/kg rectally during the operation. Serum was assayed for paracetamol concentration in 40 of these infants at 5, 8, 11, 14, 17 and 20 h postoperatively. Urine samples were collected every 3 h for 24 h in 15 of these infants. The clearances of paracetamol to glucuronide and sulphate metabolites as well as the urinary clearance of unmetabolised paracetamol were estimated using non-linear, mixed-effects models.

Results: Mean (+/-SD) age and weight of the patients were 11.8+/-2.5 months and 9.1+/-1.9 kg. Clearances of paracetamol to paracetamol-glucuronide (%CV) and to paracetamol-sulphate were 6.6 (11.5) l/h and 7.5 (11.5) l/h respectively, standardised to a 70-kg person using allometric "1/4 power" models. Glucuronide formation clearance, but not sulphate formation, was related to age and increased with age from a predicted value in a neonate of 2.73 l/h/70 kg to a mature value of 6.6 l/h/70 kg with a maturation half-life of 8.09 months. Urine clearance of paracetamol-glucuronide, paracetamol-sulphate and unchanged paracetamol (%CV) were, respectively, 2.65, 3.03 and 0.55 (28) l/h/70 kg. The urine clearance of unchanged paracetamol and metabolites was related to urine volume flow rate. Clearance attributable to pathways other than these measured in urine was not identifiable. The glucuronide/sulphate formation clearance ratio was 0.69 at 12 months of age. Sulphate metabolism contributed 50% towards paracetamol clearance.

Conclusion: Glucuronide formation clearance increases with age in the infant age range but sulphate formation does not. Renal clearance of paracetamol and its metabolites increases with urine flow rate. This and other studies show that paracetamol metabolism to glucuronide appears to be similar in infants and children, but in adults is increased in comparison with children. Oxidative pathways were undetectable in this infant study and may explain, in part, the reduced incidence of hepatotoxicity in infants.

PubMed Disclaimer

Comment in

  • No urine, no urinary clearance.
    Anderson BJ, Holford NH. Anderson BJ, et al. Eur J Clin Pharmacol. 2004 Jun;60(4):297. doi: 10.1007/s00228-004-0777-5. Epub 2004 May 18. Eur J Clin Pharmacol. 2004. PMID: 15148556 No abstract available.

Similar articles

Cited by

References

    1. Eur J Clin Pharmacol. 1988;35(1):109-11 - PubMed
    1. Eur J Clin Pharmacol. 1990;39(2):143-8 - PubMed
    1. Clin Pharmacokinet. 1991 Feb;20(2):167-73 - PubMed
    1. Clin Pharmacol Ther. 2000 Mar;67(3):275-82 - PubMed
    1. Arch Dis Child Fetal Neonatal Ed. 1999 Jan;80(1):F59-63 - PubMed

Publication types

LinkOut - more resources